However, a meta-analysis did indicate that the effects of SGLT2 inhibitors on total stroke varied depending on baseline estimated glomerular filtration rate, with the greatest protection seen in patients with the lowest estimated glomerular filtration rate (less than 45 mL/min/1.73 m2) [17]. The gene discussed is SLC5A2; the disease is stroke disorder.